Manufacturer investigation conclusion: a direct correlation between the device and the reported events could not be conclusively established through this evaluation.Additionally, the reported low flows could not be confirmed through this evaluation as no log files were provided.Furthermore, a specific cause of the reported low flows could not conclusively be determined through this evaluation multiple requests for additional information, including the return status of the device, were sent to the customer; however, no response has been received at this time.The device history records were reviewed and showed no deviations from manufacturing or quality assurance specifications.Implant kit was shipped to the customer on (b)(6) 2017.The current revision of the heartmate ii left ventricular assist system (lvas) instructions for use (ifu) lists adverse events that may be associated with the use of the heartmate ii left ventricular assist system, including death and renal dysfunction.Pump performance monitoring outlines different pump parameters and describes how pump performance is sensitive to changes in systemic vascular resistance and left ventricular filling.The pump flow section explains that pump flow is estimated based on pump power.Additionally, the ifu explains that physiological factors that affect the filling of the pump, such as hypovolemia or postural hypotension, can result in reduced pump flows as long as the condition persists.The alarms and troubleshooting section of this ifu describes all alarm conditions, including the low flow hazard alarm.No further information was provided.The manufacturer is closing the file on this event.
|